Lobbying Filing Details

Total Spending

$60,000

Activities

1

Lobbyists

1

Gov't Entities

2

Filing Information

Filing UUID:: b2c728e8-3979-4769-83d1-af8aa161da4c
Type:: Q1 - 1st Quarter - Report
Period:: 2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:: April 20, 2026 at 7:01 PM
Income:: $60,000
Expenses:: $0
Document URL:: View Submission

Quick Info

Document Type: text/html
Posted By: John McManus

Registrant

THE MCMANUS GROUP

Consulting

Washington, District of Columbia

Client

AMGEN

District of Columbia, United States of America

Lobbying Activities (1)

Activity 1

Medicare/Medicaid

Access and reimbursement for Part B and Part D drugs. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement under Medicare Part B drugs. Policies related to the Most Favored Nation Drug Pricing Model

Lobbyists (1)

JOHN MCMANUS

Government Entities (2)

SENATE
HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.